Blok Tyler 4

What Happened

• Blok Tyler, Chief Legal Officer of CytoDyn Inc. (CYDY), was granted 3,249,794 shares on March 20, 2026. The grant is reported as an award/derivative (code A) with a $0.00 acquisition price (no cash paid at grant).
• The award was approved by the company’s Compensation Committee and uses shares reserved under the Issuer’s 2012 Equity Incentive Plan.

Key Details

• Transaction date: March 20, 2026; Form 4 filed: March 24, 2026 (timely filing).
• Grant amount and price: 3,249,794 shares @ $0.00 (derivative award).
• Vesting: 812,448 shares vest on March 20, 2027; the remaining shares vest in approximately equal monthly installments on the same day each month from April 2027 through March 2030 (per footnote).
• Source of shares: specifically reserved shares under the 2012 Equity Incentive Plan, as amended.
• Shares owned after transaction: not disclosed in this filing.
• Filing status: filed within the SEC two-business-day requirement for Form 4 submissions (no late flag indicated).

Context

• This is an equity award (grant) rather than an open-market purchase or sale; it represents compensation tied to future service/vesting. Such awards are routine for executives and do not, by themselves, indicate immediate buying or selling of shares.
• Because vesting is spread over multiple future dates, the economic interest in the shares accrues over time as vesting occurs.